Concordia (CXRX) Says CEO Thompson Sold Stock as Part of Margin Call; Comments on Pernix Therapeutics (PTX) M&A Chatter
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/26/2024
- Wall Street stocks fall as weak GDP growth spreads rate-cut gloom
- Q1 US GDP shows surprise slowing and uncomfortable inflation
- Alphabet (GOOGL) soars 16% on Q1 results beat, first-ever dividend
- Meta shares dip on softer Q2 revenue guidance, elevated AI spending plans
- Oil settles higher as weak U.S. economic growth offset by supply concerns
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
Concordia International Corp. Issues Statement On Sale Of Company Stock
August 22, 2016 5:00 PM EDTOAKVILLE, ON, Aug. 22, 2016 /PRNewswire/ -Â Concordia International Corp. ("Concordia" or the "Company") (NASDAQ: CXRX) (TSX: CXR), an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs, stated that Concordia's Chairman and Chief Executive Officer Mark Thompson was notified earlier today of the sale of 505,000 of his shares as part of a margin call.
These shares were not granted to Mr. Thompson as compensation. The shares were pledged to secure loans made to Mr. Thompson, and the sales terms were agreed upon, prior to the... More
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Concordia International Corp. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
August 18, 2016 1:43 PM EDTIRVINE, Calif.--(BUSINESS WIRE)-- Khang & Khang LLP (the Firm) announces that a class action lawsuit was filed against Concordia International Corp. (Concordia or the Company) (Nasdaq: CXRX). Investors, who purchased or otherwise acquired shares between November 12, 2015 and August 12, 2016 inclusive (the Class Period), are encouraged to contact the Firm prior to the October 14, 2016 lead plaintiff motion deadline.
If you purchased shares of Concordia during the Class Period, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue,... More
